Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001352414-12-000013)

Filing Details

Accession Number:: 0001352414-12-000013
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-09-14 16:19:26
Reporting Period:: 2012-09-12

Filing Date:: 2012-09-14
Accepted Time:: 2012-09-14 16:19:26
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
899923	Myriad Genetics Inc	MYGN	In Vitro & In Vivo Diagnostic Substances (2835)	870494517

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1352414	S James Evans	320 Wakara Way Salt Lake City UT 84108	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-09-13	5,494	$3.80	52,265	No	4	M	Direct
Common Stock	Disposition	2012-09-13	5,494	$27.10	46,771	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2012-09-13	5,494	$0.00	5,494	$3.80
Common Stock	Non-Qualified Stock Option (right to buy)	Acquisiton	2012-09-12	190,000	$0.00	190,000	$27.07

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2013-02-13	No	4	M	Direct
190,000		2022-09-12	No	4	A	Direct

Footnotes

The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.